Menu Search
Equities

Q linea AB

QLINEA:STO

Q linea AB

Actions
Health CareMedical Equipment and Services
  • Price (SEK)1.11
  • Today's Change0.014 / 1.27%
  • Shares traded96.26k
  • 1 Year change-63.11%
  • Beta1.1137
Data delayed at least 15 minutes, as of Nov 22 2024 13:28 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in SEKIncome statement in SEKView more

Year on year Q linea AB had revenues fall -65.28% from 12.79m to 4.44m, though the company grew net income from a loss of 268.69m to a smaller loss of 229.37m.
Gross margin-124.10%
Net profit margin-9,635.17%
Operating margin-9,615.01%
Return on assets-103.05%
Return on equity-161.88%
Return on investment-149.74%
More ▼

Cash flow in SEKView more

In 2023, Q linea AB increased its cash reserves by 12.37%, or 9.02m. Cash Flow from Financing totalled 245.41m or 5,527.18% of revenues. In addition the company used 228.52m for operations while cash used for investing totalled 7.77m.
Cash flow per share-1.71
Price/Cash flow per share--
Book value per share0.219
Tangible book value per share0.1768
More ▼

Balance sheet in SEKView more

Q linea AB appears to have a strong balance sheet and has grown its cash reserves consistently over the last four years to total 81.90m. In fact, 0.64% of the value of Q linea AB shares can be attributed to this cash.
Current ratio0.7885
Quick ratio0.4141
Total debt/total equity3.60
Total debt/total capital0.7825
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.